An exploratory biomarker trial of temsirolimus in subjects with newly diagnosed advanced stage squamous cell carcinoma of the head and neck
Phase of Trial: Phase II
Latest Information Update: 17 Sep 2007
At a glance
- Drugs Temsirolimus (Primary)
- Indications Head and neck cancer
- Focus Biomarker; Therapeutic Use
- 17 Sep 2007 Status changed from in progress to completed.
- 26 Nov 2005 New trial record.